Dubai Silicon Oasis and TUM International Explore Research and Technology Transfer
Dubai Silicon Oasis and TUM International are exploring opportunities to advance applied research and technology transfer.
Related stories
BioMarin Licenses Fabry Disease Therapy From GC Biopharma and Hanmi Pharm
BioMarin entered an exclusive license for a Fabry disease therapy from GC Biopharma and Hanmi Pharm.
M impact | EQUITY | Oct 29, 2026, 12:50 PM UTC
National Medical Care Reports Q3 Net Profit of SAR 87.024 Million
M impact | EQUITY | Oct 29, 2026, 12:50 PM UTC
Silicom Reports Q3 Revenue of $26.7 Million, Adjusted EPS of $0.04
M impact | EQUITY | Oct 29, 2026, 12:50 PM UTC
Al Baha reports Q3 net profit of SAR 2.66855 million
M impact | EQUITY | Oct 29, 2026, 12:49 PM UTC
Harley-Davidson Q3 EPS Falls 87% to $0.40; Revenue Drops 19%
Harley-Davidson reported Q3 2026 diluted EPS of $0.40, down 87% year over year, and revenue of $1.08 billion, down 19%.
M impact | EQUITY | Oct 29, 2026, 12:49 PM UTC
Mastercard Q3 Cross-Border Volume Growth Reaches 11%
Mastercard reported Q3 cross-border volume growth of 11% on a local currency basis.
L impact | EQUITY | Oct 29, 2026, 12:49 PM UTC